Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for primary prevention of CV risk in CKD (AASER)
NCT01709994Phase 3Unknown
- Start
- May 2010
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in cardiovascular disease (CVD). Status: unknown.
02
Drugs
aspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01709994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709994.